Knight Therapeutics Inc. (TSX:GUD)
6.16
-0.06 (-0.96%)
At close: Mar 6, 2026
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
555.50K CAD
Profits / Employee
-4.69K CAD
Market Cap
611.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Verano Holdings | 3,800 |
| Cresco Labs | 2,900 |
| Cipher Pharmaceuticals | 5 |
| TerrAscend | 1,163 |
| Cronos Group | 459 |
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
Knight Therapeutics News
- 17 days ago - Incyte (INCY) Expands Latin American Partnership with Knight Therapeutics - GuruFocus
- 17 days ago - Knight Therapeutics Announces Regulatory Submission of NIKTIMVO® (Axatilimab) in Brazil - GlobeNewsWire
- 17 days ago - Knight Therapeutics Announces Regulatory Submission of NIKTIMVO (Axatilimab) in Brazil - Wallstreet:Online
- 2 months ago - Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. (GUD:CA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Knight Therapeutics Reports Third Quarter 2025 Results - GlobeNewsWire
- 4 months ago - Knight Announces Closing of US$100 Million Revolving Credit Facility - GlobeNewsWire
- 4 months ago - Notice of Knight Therapeutics' Third Quarter 2025 Results Conference Call - GlobeNewsWire